Gastrointestinal Trials

IMbrave050 A phase III, multicentre, randomized, Open-label study of atezolizumab (anti-pd-l1 antibody) plus bevacizumab Versus active surveillance as adjuvant Therapy in patients with hepatocellular Carcinoma at high risk of recurrence after surgical resection or ablation.

2020 Quality Statement


“Excellence in Care”

The provision of excellent care to Riverina Cancer Care Centre (RCCC) patients is achieved by Centre staff and Volunteers’ participation in and observance of the Centre’s Quality system in the performance of their roles. Cooperation, collaboration, communication and mutual respect are critical to provision of excellent care.

Read more...

 

 

Location

RCCC Opening Hours

MON 7:30am - 5:00pm
TUE 7:30am - 5:00pm
WED 7:30am - 5:00pm
THU 7:30am - 5:00pm
FRI 7:30am - 5:00pm
SAT closed
SUN closed

After Hours Emergency: Please access your local hospital emergency department.

Contact Us